Literature DB >> 19759117

18F-FDG PET/CT identifies patients at risk for future vascular events in an otherwise asymptomatic cohort with neoplastic disease.

Axel Rominger1, Tobias Saam, Sarah Wolpers, Clemens C Cyran, Michael Schmidt, Stefan Foerster, Konstantin Nikolaou, Maximilian F Reiser, Peter Bartenstein, Marcus Hacker.   

Abstract

UNLABELLED: Our objective was to evaluate the association of arterial (18)F-FDG uptake and calcifications in large arteries as detected by (18)F-FDG PET/CT with the subsequent occurrence of vascular events in otherwise asymptomatic cancer patients.
METHODS: Clinical follow-up information was obtained for 932 cancer patients examined with whole-body (18)F-FDG PET/CT (median follow-up time, 29 mo). Among this cohort, 279 patients had died from their oncologic disease. In 15 of 932 patients (1.6%), a vascular event, defined as ischemic stroke, myocardial infarction, or revascularization, was registered. The maximal standardized uptake value (SUV) was divided by the blood-pool SUV, yielding a target-to-background ratio (TBR) for each arterial segment. The mean TBR as well as a calcified plaque sum score per patient were calculated in the major vessels: ascending, descending, and abdominal aorta, aortic arch, as well as iliac and carotid arteries.
RESULTS: A significant correlation was observed between mean TBR and calcified plaque sum (P < 0.001). Although calcified plaque sum significantly correlated with all conventional risk factors for vascular events, mean TBR correlated only with age, the male sex, and hypertension. The Cox regression hazard model identified a mean TBR >or= 1.7 and a calcified plaque sum >or= 15 as independent predictors for the occurrence of a vascular event. Patients with both mean TBR and calcified plaque sum above these thresholds were identified as having the highest risk for a future vascular event. However, a mean TBR >or= 1.7 had greater prognostic value than did a calcified plaque sum >or= 15.
CONCLUSION: In a large cohort of cancer patients, increased (18)F-FDG uptake in major arteries emerged as the strongest predictor of a subsequent vascular event. Concomitant severe vascular calcifications seemed to impart a particularly high risk. Given the small event rate in the present study, larger, prospective trials of patients without cancer are required to substantiate these promising results.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19759117     DOI: 10.2967/jnumed.109.065151

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  118 in total

1.  Cardiovascular disease in HIV: traditional and nontraditional risk factors.

Authors:  Steven K Grinspoon
Journal:  Top Antivir Med       Date:  2014 Sep-Oct

Review 2.  Imaging of coronary inflammation with FDG-PET: feasibility and clinical hurdles.

Authors:  Ian S Rogers; Ahmed Tawakol
Journal:  Curr Cardiol Rep       Date:  2011-04       Impact factor: 2.931

3.  Monitoring anti-inflammatory therapies in patients with atherosclerosis: FDG PET emerges as the method of choice.

Authors:  M Hacker
Journal:  Eur J Nucl Med Mol Imaging       Date:  2012-03       Impact factor: 9.236

Review 4.  The year in molecular imaging.

Authors:  Eric A Osborn; Farouc A Jaffer
Journal:  JACC Cardiovasc Imaging       Date:  2010-11

5.  High-risk plaque features can be detected in non-stenotic carotid plaques of patients with ischaemic stroke classified as cryptogenic using combined (18)F-FDG PET/MR imaging.

Authors:  Fabien Hyafil; Andreas Schindler; Dominik Sepp; Tilman Obenhuber; Anna Bayer-Karpinska; Tobias Boeckh-Behrens; Sabine Höhn; Marcus Hacker; Stephan G Nekolla; Axel Rominger; Martin Dichgans; Markus Schwaiger; Tobias Saam; Holger Poppert
Journal:  Eur J Nucl Med Mol Imaging       Date:  2015-10-03       Impact factor: 9.236

6.  Impact of cardiovascular risk factors on vessel wall inflammation and calcified plaque burden differs across vascular beds: a PET-CT study.

Authors:  Frederik F Strobl; Axel Rominger; Sarah Wolpers; Carsten Rist; Fabian Bamberg; Kolja M Thierfelder; Konstantin Nikolaou; Christopher Uebleis; Marcus Hacker; Maximilian F Reiser; Tobias Saam
Journal:  Int J Cardiovasc Imaging       Date:  2013-08-24       Impact factor: 2.357

7.  Identification of inflamed atherosclerotic lesions in vivo using PET-CT.

Authors:  Mateja Kaja Jezovnik; Nina Zidar; Luka Lezaic; Borut Gersak; Pavel Poredos
Journal:  Inflammation       Date:  2014-04       Impact factor: 4.092

8.  Subclinical vasculitis as a potential mechanism to explain the heightened cardiovascular risk in rheumatoid arthritis.

Authors:  Zahi A Fayad; Jeffrey D Greenberg; Jan Bucerius
Journal:  Circulation       Date:  2012-10-24       Impact factor: 29.690

Review 9.  Imaging of inflammation and calcification in aortic stenosis.

Authors:  Marc R Dweck; Nikhil V Joshi; James H F Rudd; David E Newby
Journal:  Curr Cardiol Rep       Date:  2013-01       Impact factor: 2.931

10.  Arterial inflammation in bronchial asthma.

Authors:  Jayanthi Vijayakumar; Sharath Subramanian; Parmanand Singh; Erin Corsini; Sara Fontanez; Meredith Lawler; Rebecca Kaplan; Thomas J Brady; Udo Hoffmann; Ahmed Tawakol
Journal:  J Nucl Cardiol       Date:  2013-03-23       Impact factor: 5.952

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.